Literature DB >> 19352737

[Extracorporeal photopheresis].

U Just1, R Knobler.   

Abstract

Photopheresis, originally developed in dermatology, has become a treatment method accepted across various disciplines. A basic knowledge of photomedicine and photobiology is one of the cornerstones of dermatology. Even if photopheresis is used for indications that are not specifically dermatological, e.g. graft-versus-host disease or Crohn's disease, an experienced dermatologist trained in the use of photopheresis should therefore always be consulted.

Entities:  

Mesh:

Year:  2009        PMID: 19352737     DOI: 10.1007/s00105-008-1500-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

Review 1.  Photopheresis: clinical applications and mechanism of action.

Authors:  A H Rook; K R Suchin; D M Kao; E K Yoo; W H Macey; B J DeNardo; P G Bromely; Y Geng; J M Junkins-Hopkins; S R Lessin
Journal:  J Investig Dermatol Symp Proc       Date:  1999-09

2.  Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.

Authors:  P Heald; A Rook; M Perez; B Wintroub; R Knobler; B Jegasothy; F Gasparro; C Berger; R Edelson
Journal:  J Am Acad Dermatol       Date:  1992-09       Impact factor: 11.527

3.  Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy.

Authors:  Michael Radenhausen; Silke Michelsen; Gerd Plewig; Falk G Bechara; Peter Altmeyer; Klaus Hoffmann
Journal:  J Dermatol       Date:  2004-12       Impact factor: 4.005

Review 4.  Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas.

Authors:  R Knobler; M Girardi
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

5.  Induction of human tumor-loaded dendritic cells.

Authors:  C L Berger; A L Xu; D Hanlon; C Lee; J Schechner; E Glusac; I Christensen; E Snyder; V Holloway; R Tigelaar; R L Edelson
Journal:  Int J Cancer       Date:  2001-02-15       Impact factor: 7.396

6.  Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.

Authors:  J Bladon; P C Taylor
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

Review 7.  Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection.

Authors:  Roberto Dall'Amico; Luisa Murer
Journal:  Transfus Apher Sci       Date:  2002-06       Impact factor: 1.764

8.  Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

Authors:  M L Barr; B M Meiser; H J Eisen; R F Roberts; U Livi; R Dall'Amico; R Dorent; J G Rogers; B Radovancević; D O Taylor; V Jeevanandam; C C Marboe
Journal:  N Engl J Med       Date:  1998-12-10       Impact factor: 91.245

9.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

Authors:  R Edelson; C Berger; F Gasparro; B Jegasothy; P Heald; B Wintroub; E Vonderheid; R Knobler; K Wolff; G Plewig
Journal:  N Engl J Med       Date:  1987-02-05       Impact factor: 91.245

10.  Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.

Authors:  Ettore Biagi; Iolanda Di Biaso; Veronica Leoni; Giuseppe Gaipa; Vincenzo Rossi; Cristina Bugarin; Giuliano Renoldi; Matteo Parma; Adriana Balduzzi; Paolo Perseghin; Andrea Biondi
Journal:  Transplantation       Date:  2007-07-15       Impact factor: 4.939

View more
  1 in total

Review 1.  [Graft-versus-host disease (GvHD) - an update. Part 2: prognosis and therapy of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.